Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.
2.

Schizophrenic patients' subjective reasons for compliance and noncompliance with neuroleptic treatment.

Löffler W, Kilian R, Toumi M, Angermeyer MC.

Pharmacopsychiatry. 2003 May;36(3):105-12.

PMID:
12806568
3.

Rating of medication influences (ROMI) scale in schizophrenia.

Weiden P, Rapkin B, Mott T, Zygmunt A, Goldman D, Horvitz-Lennon M, Frances A.

Schizophr Bull. 1994;20(2):297-310.

PMID:
7916162
4.

Attitudes towards neuroleptic treatment: reliability and validity of the attitudes towards neuroleptic treatment (ANT) questionnaire.

Kampman O, Lehtinen K, Lassila V, Leinonen E, Poutanen O, Koivisto A.

Schizophr Res. 2000 Oct 27;45(3):223-34.

PMID:
11042440
5.

[Compliance in schizophrenia: predictive factors, therapeutical considerations and research implications].

Misdrahi D, Llorca PM, Lançon C, Bayle FJ.

Encephale. 2002 May-Jun;28(3 Pt 1):266-72. French.

PMID:
12091789
6.

Compliance in schizophrenia: psychopathology, side effects, and patients' attitudes toward the illness and medication.

Rettenbacher MA, Hofer A, Eder U, Hummer M, Kemmler G, Weiss EM, Fleischhacker WW.

J Clin Psychiatry. 2004 Sep;65(9):1211-8.

PMID:
15367047
7.

Subjective well-being under the neuroleptic treatment and its relevance for compliance.

Naber D, Karow A, Lambert M.

Acta Psychiatr Scand Suppl. 2005;(427):29-34. Review.

PMID:
15943008
8.

[Validation of the Temporal Experience of Pleasure Scale (TEPS) in a French-speaking environment].

Favrod J, Ernst F, Giuliani F, Bonsack C.

Encephale. 2009 Jun;35(3):241-8. doi: 10.1016/j.encep.2008.02.013. Epub 2008 Jul 7. French.

PMID:
19540410
9.

Subjective illness theory and antipsychotic medication compliance by patients with schizophrenia.

Holzinger A, Loffler W, Muller P, Priebe S, Angermeyer MC.

J Nerv Ment Dis. 2002 Sep;190(9):597-603.

PMID:
12357093
10.

A scale for detection of negative attitudes towards medication among relatives of schizophrenic patients.

Mantonakis J, Markidis M, Kontaxakis V, Liakos A.

Acta Psychiatr Scand. 1985 Feb;71(2):186-9.

PMID:
2858150
11.

Indicators of medication compliance in first-episode psychosis.

Kampman O, Laippala P, Väänänen J, Koivisto E, Kiviniemi P, Kilkku N, Lehtinen K.

Psychiatry Res. 2002 May 15;110(1):39-48.

PMID:
12007592
12.

Psychosocial and socio-demographic correlates of medication compliance among people with schizophrenia.

Tsang HW, Fung KM, Corrigan PW.

J Behav Ther Exp Psychiatry. 2009 Mar;40(1):3-14. doi: 10.1016/j.jbtep.2008.02.003. Epub 2008 Mar 18.

PMID:
18417098
13.

Olanzapine orally disintegrating tablets in the treatment of acutely ill non-compliant patients with schizophrenia.

Kinon BJ, Hill AL, Liu H, Kollack-Walker S.

Int J Neuropsychopharmacol. 2003 Jun;6(2):97-102. Erratum in: Int J Neuropsychopharmacol. 2003 Sep;6(3):313.

PMID:
12890301
14.

Predictors of compliance with neuroleptic medication among inpatients with schizophrenia: a discriminant function analysis.

Donohoe G, Owens N, O'Donnell C, Burke T, Moore L, Tobin A, O'Callaghan E.

Eur Psychiatry. 2001 Aug;16(5):293-8.

PMID:
11514132
15.

Clinical symptomatology and drug compliance in schizophrenic patients.

Bartkó G, Herczeg I, Zádor G.

Acta Psychiatr Scand. 1988 Jan;77(1):74-6.

PMID:
2894746
16.

A self-rating scale for measuring neuroleptic side-effects. Validation in a group of schizophrenic patients.

Day JC, Wood G, Dewey M, Bentall RP.

Br J Psychiatry. 1995 May;166(5):650-3.

PMID:
7620752
18.

Compliance with neuroleptic medication in outpatients with schizophrenia; relationship to subjective response to neuroleptics; attitudes to medication and insight.

Garavan J, Browne S, Gervin M, Lane A, Larkin C, O'Callaghan E.

Compr Psychiatry. 1998 Jul-Aug;39(4):215-9.

PMID:
9675506
19.

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.

Lewis SW, Davies L, Jones PB, Barnes TR, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G.

Health Technol Assess. 2006 May;10(17):iii-iv, ix-xi, 1-165.

20.

Performance of the Italian version of the subjective well-being under neuroleptic (SWN) scale in schizophrenic outpatients.

Balestrieri M, Giaroli G, Mazzi M, Bellantuono C.

Pharmacopsychiatry. 2006 May;39(3):81-4.

PMID:
16721695

Supplemental Content

Support Center